[evaluation of protocols for rush subcutaneous immunotherapy with standardized house dust mite extracts].

CONCLUSION: In rSCIT using standardized house dust mite extract, lowering the target dose at the end of the rush phase and delaying the administration of the maintenance dose may reduce SR and increase the reached amount of antigen. PMID: 32051368 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32051368?dopt=Abstract

Source: Arerugi - February 15, 2020 Category: Allergy & Immunology Authors: Hamada M Tags: Arerugi Source Type: research

More News: Allergy & Immunology | Immunotherapy | Japan Health | Science